An Israeli hospital says it has used an under-trial artificial intelligence technology to give patients immediate results for a deep-dive report on their tumor’s DNA — eliminating days they would have spent waiting before getting treatment for their brain cancer.

Tel Aviv Sourasky Medical Center announced this week that it had successfully used AI to deliver accurate genomic analysis to two brain cancer patients, calling the breakthrough “exceptional.”

The doctors used Imagene, an Israeli AI platform that instantly analyzes the tumor and delivers an in-depth genomic analysis, as part of a trial that is being conducted at Sourasky and at Sheba Medical Center. The trial is intended to lead to regulatory approval of the tech for widespread distribution.

Genomic analysis is a process that gives doctors a highly detailed picture of their patient’s tumor, with information on processes through which it responds to its environment, and its DNA sequence.

Still used only on a minority of patients, it is growing in popularity and seen as key in the ongoing shift towards personalized medicine tailored to the characteristics of different patients’ tumors.

But it is a time-consuming process that takes days or weeks. If doctors are waiting for information before deciding a treatment path, this can cause the loss of potentially lifesaving days to fight the cancer.

Sourasky doctors announced that the AI algorithms detected the cancer mutation that led to the tumors. Conclusions were confirmed by PCR test, and the patients started personalized treatment within a day.

“We are so used to waiting a long time for molecular cancer testing while patients deteriorate, that such a breakthrough technology, enabling treatment initiation within a day is exceptional,” said Prof. Ido Wolf, director of the Oncology Department at Sourasky.

The technology, designed to work with a wide range of tumors, was developed by Dean Bitan, a computer scientist who decided to focus on cancer tech after his mother was diagnosed with stage 4 ovarian cancer. He established the Imagene startup, and worked on ways to use AI to search for biomarkers in a digitized biopsy image.

Bitan said his hope is that his platform won’t only make genomic analysis quicker, but also more widely available.

Today only a minority of cancer patients undergo genomic analysis and have their treatment personalized by findings. The problem, in part, is that it is time-consuming and expensive.

“This technology is about democratizing genomic analysis, making it available to all in real-time,” he told The Times of Israel. “It can actually preserve people’s lives.”

I joined The Times of Israel after many years covering US and Israeli politics for Israeli news outlets.

I believe responsible coverage of Israeli politicians means presenting a 360 degree view of their words and deeds – not only conveying what occurs, but also what that means in the broader context of Israeli society and the region.

That’s hard to do because you can rarely take politicians at face value – you must go the extra mile to present full context and try to overcome your own biases.

I’m proud of our work that tells the story of Israeli politics straight and comprehensively. I believe Israel is stronger and more democratic when professional journalists do that tough job well.

Your support for our work by joining The Times of Israel Community helps ensure we can continue to do so.

Thank you,
Tal Schneider, Political Correspondent

We’re really pleased that you’ve read X Times of Israel articles in the past month.

That’s why we started the Times of Israel ten years ago - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.

So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.

For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.

Thank you,
David Horovitz, Founding Editor of The Times of Israel

QOSHE - Israeli hospital: new tech gave instant DNA info on tumors, jump starts treatment - Nathan Jeffay
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Israeli hospital: new tech gave instant DNA info on tumors, jump starts treatment

15 27 16
11.11.2022

An Israeli hospital says it has used an under-trial artificial intelligence technology to give patients immediate results for a deep-dive report on their tumor’s DNA — eliminating days they would have spent waiting before getting treatment for their brain cancer.

Tel Aviv Sourasky Medical Center announced this week that it had successfully used AI to deliver accurate genomic analysis to two brain cancer patients, calling the breakthrough “exceptional.”

The doctors used Imagene, an Israeli AI platform that instantly analyzes the tumor and delivers an in-depth genomic analysis, as part of a trial that is being conducted at Sourasky and at Sheba Medical Center. The trial is intended to lead to regulatory approval of the tech for widespread distribution.

Genomic analysis is a process that gives doctors a highly detailed picture of their patient’s tumor, with information on processes through which it responds to its environment, and its DNA sequence.

Still used only on a minority of patients, it is growing in popularity and seen as key in the ongoing shift towards personalized........

© The Times of Israel


Get it on Google Play